Clinical trial

Study on the Usage, Dosing, Tolerability, and Effectiveness of Kaletra Tablet

NCT01097655

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2006-08-01

PhaseN/A

Study timeline

Study start (unknown)2006-08-01Date precision: month

Registry last updated2017-05-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Human Immunodeficiency Virusunresolved

Interventions

Sponsors & collaborators

AbbVie (prior sponsor, Abbott)lead sponsor

Veeda Clinical Researchcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01097655 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.